Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors (CROSBI ID 725026)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Baković, Matea ; Ortner Hadžiabdić, Maja ; Silovski, Tajana ; Sertić, Miranda
engleski
Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors
Analysis of venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer, who are treated with CDK4/6 inhibitors
Venous thromboembolism ; HR+/HER2- breast cancer ; CDK4/6 inhibitors
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
394
2022.
objavljeno
Podaci o matičnoj publikaciji
Knjiga sažetaka FIP World Congress of Pharmacy and Pharmaceutical Sciences 2022, International Pharmaceutical Federation, 2022
Sevilla: International Pharmaceutical Federation (FIP)
Podaci o skupu
80th FIP World Congress of Pharmacy and Pharmaceutical Sciences (FIP Seville 2022)
poster
18.09.2022-22.09.2022
Sevilla, Španjolska
